These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 38870368)

  • 21. A double-blind comparison of onabotulinumtoxina (BOTOX) and topiramate (TOPAMAX) for the prophylactic treatment of chronic migraine: a pilot study.
    Mathew NT; Jaffri SF
    Headache; 2009; 49(10):1466-78. PubMed ID: 19912346
    [TBL] [Abstract][Full Text] [Related]  

  • 22. OnabotulinumtoxinA for the treatment of headache.
    Ashkenazi A; Blumenfeld A
    Headache; 2013 Sep; 53 Suppl 2():54-61. PubMed ID: 24024603
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sequential administration of peripheral nerve blocks and onabotulinumtoxinA for the treatment of chronic migraine and other headache disorders-A retrospective tolerability and safety study.
    Anderson CC; Iser CR; Hirte IL; Boddu S; Girardo ME; VanderPluym JH; Starling AJ
    Headache; 2024 Jun; 64(6):663-673. PubMed ID: 38700250
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quarterly repeat cycles of onabotulinumtoxinA in chronic migraine patients: the benefits of the prolonged treatment on the continuous responders and quality-of-life conversion rate in a real-life setting.
    Santoro A; Fontana A; Miscio AM; Zarrelli MM; Copetti M; Leone MA
    Neurol Sci; 2017 Oct; 38(10):1779-1789. PubMed ID: 28726049
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Scar neuromas as triggers for headache after craniotomy: clinical evidence.
    Ferreira Kdos S; Dach F; Speciali JG
    Arq Neuropsiquiatr; 2012 Mar; 70(3):206-9. PubMed ID: 22392114
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prospective analysis of the use of OnabotulinumtoxinA (BOTOX) in the treatment of chronic migraine; real-life data in 254 patients from Hull, U.K.
    Khalil M; Zafar HW; Quarshie V; Ahmed F
    J Headache Pain; 2014 Sep; 15(1):54. PubMed ID: 25178393
    [TBL] [Abstract][Full Text] [Related]  

  • 27. OnabotulinumtoxinA for treatment of chronic migraine: pooled analyses of the 56-week PREEMPT clinical program.
    Aurora SK; Winner P; Freeman MC; Spierings EL; Heiring JO; DeGryse RE; VanDenburgh AM; Nolan ME; Turkel CC
    Headache; 2011 Oct; 51(9):1358-73. PubMed ID: 21883197
    [TBL] [Abstract][Full Text] [Related]  

  • 28. OnabotulinumtoxinA injections in chronic migraine, targeted to sites of pericranial myofascial pain: an observational, open label, real-life cohort study.
    Ranoux D; Martiné G; Espagne-Dubreuilh G; Amilhaud-Bordier M; Caire F; Magy L
    J Headache Pain; 2017 Dec; 18(1):75. PubMed ID: 28733943
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New Daily Persistent Headache and OnabotulinumtoxinA Therapy.
    Ali A; Kriegler J; Tepper S; Vij B
    Clin Neuropharmacol; 2019; 42(1):1-3. PubMed ID: 30499777
    [TBL] [Abstract][Full Text] [Related]  

  • 30. OnabotulinumtoxinA improves quality of life and reduces impact of chronic migraine.
    Lipton RB; Varon SF; Grosberg B; McAllister PJ; Freitag F; Aurora SK; Dodick DW; Silberstein SD; Diener HC; DeGryse RE; Nolan ME; Turkel CC
    Neurology; 2011 Oct; 77(15):1465-72. PubMed ID: 21956721
    [TBL] [Abstract][Full Text] [Related]  

  • 31. OnabotulinumtoxinA for hemicrania continua: open label experience in 9 patients.
    Miller S; Correia F; Lagrata S; Matharu MS
    J Headache Pain; 2015 Mar; 16():19. PubMed ID: 25902798
    [TBL] [Abstract][Full Text] [Related]  

  • 32. FORWARD Study: Evaluating the Comparative Effectiveness of OnabotulinumtoxinA and Topiramate for Headache Prevention in Adults With Chronic Migraine.
    Rothrock JF; Adams AM; Lipton RB; Silberstein SD; Jo E; Zhao X; Blumenfeld AM;
    Headache; 2019 Nov; 59(10):1700-1713. PubMed ID: 31559634
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The efficacy of onabotulinumtoxinA in patients with previous failed augmentation cystoplasty: Cohort series and literature review.
    Toia B; Pakzad MH; Hamid R; Wood DN; Greenwell TJ; Ockrim JL
    Neurourol Urodyn; 2020 Aug; 39(6):1831-1836. PubMed ID: 32572987
    [TBL] [Abstract][Full Text] [Related]  

  • 34. OnabotulinumtoxinA injection in the treatment of chronic migraine.
    Wang YF
    Prog Brain Res; 2020; 255():171-206. PubMed ID: 33008506
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Battling Neuropathic Scar Pain With Botulinum Toxin.
    Schuler A; Veenstra J; Ozog D
    J Drugs Dermatol; 2019 Sep; 18(9):937-938. PubMed ID: 31524351
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A multi-center double-blind pilot comparison of onabotulinumtoxinA and topiramate for the prophylactic treatment of chronic migraine.
    Cady RK; Schreiber CP; Porter JA; Blumenfeld AM; Farmer KU
    Headache; 2011 Jan; 51(1):21-32. PubMed ID: 21070228
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Randomized, double-blind, placebo controlled pilot study of intradetrusor injections of onabotulinumtoxinA for the treatment of refractory overactive bladder persisting following surgical management of benign prostatic hyperplasia.
    Chughtai B; Dunphy C; Lee R; Lee D; Sheth S; Marks L; Kaplan SA; Te AE
    Can J Urol; 2014 Apr; 21(2):7217-21. PubMed ID: 24775575
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-Term Outcome of Patients With Intractable Chronic Cluster Headache Treated With Injection of Onabotulinum Toxin A Toward the Sphenopalatine Ganglion - An Observational Study.
    Aschehoug I; Bratbak DF; Tronvik EA
    Headache; 2018 Nov; 58(10):1519-1529. PubMed ID: 30216444
    [TBL] [Abstract][Full Text] [Related]  

  • 39. OnabotulinumtoxinA for treatment of chronic migraine: PREEMPT 24-week pooled subgroup analysis of patients who had acute headache medication overuse at baseline.
    Silberstein SD; Blumenfeld AM; Cady RK; Turner IM; Lipton RB; Diener HC; Aurora SK; Sirimanne M; DeGryse RE; Turkel CC; Dodick DW
    J Neurol Sci; 2013 Aug; 331(1-2):48-56. PubMed ID: 23790235
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Daily Headache in Chronic Migraine Is a Predictive Factor of Response in Patients Who Had Completed Three Sessions of OnabotulinumtoxinA.
    Martínez-Pías E; Guerrero ÁL; Sierra Á; Trigo J; García-Azorín D
    Toxins (Basel); 2021 Jun; 13(6):. PubMed ID: 34205832
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.